These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23469193)

  • 1. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
    Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
    PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2.
    Fortin Ensign SP; Mathews IT; Eschbacher JM; Loftus JC; Symons MH; Tran NL
    J Biol Chem; 2013 Jul; 288(30):21887-97. PubMed ID: 23775076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
    Haile WB; Echeverry R; Wu J; Yepes M
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
    Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
    Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.
    Perez JG; Tran NL; Rosenblum MG; Schneider CS; Connolly NP; Kim AJ; Woodworth GF; Winkles JA
    Oncogene; 2016 Apr; 35(17):2145-55. PubMed ID: 26300004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.
    Tarín C; Fernández-Laso V; Sastre C; Madrigal-Matute J; Gómez M; Zaragoza C; Egido J; Burkly LC; Martín-Ventura JL; Blanco-Colio LM
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
    Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TWEAK-Fn14-RelB Signaling Cascade Promotes Stem Cell-like Features that Contribute to Post-Chemotherapy Ovarian Cancer Relapse.
    Holmberg R; Robinson M; Gilbert SF; Lujano-Olazaba O; Waters JA; Kogan E; Velasquez CLR; Stevenson D; Cruz LS; Alexander LJ; Lara J; Mu EM; Camillo JR; Bitler BG; Huxford T; House CD
    Mol Cancer Res; 2023 Feb; 21(2):170-186. PubMed ID: 36214671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
    Echeverry R; Wu F; Haile WB; Wu J; Yepes M
    J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
    Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M
    Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
    Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
    Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
    J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.
    Pelekanou V; Notas G; Kampa M; Tsentelierou E; Stathopoulos EN; Tsapis A; Castanas E
    PLoS One; 2013; 8(12):e83250. PubMed ID: 24376672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.
    Sanz AB; Sanchez-Niño MD; Carrasco S; Manzarbeitia F; Ruiz-Andres O; Selgas R; Ruiz-Ortega M; Gonzalez-Enguita C; Egido J; Ortiz A
    PLoS One; 2012; 7(10):e47440. PubMed ID: 23077618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TWEAK-Fn14 system as a potential drug target.
    Wajant H
    Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression.
    Dwyer BJ; Jarman EJ; Gogoi-Tiwari J; Ferreira-Gonzalez S; Boulter L; Guest RV; Kendall TJ; Kurian D; Kilpatrick AM; Robson AJ; O'Duibhir E; Man TY; Campana L; Starkey Lewis PJ; Wigmore SJ; Olynyk JK; Ramm GA; Tirnitz-Parker JEE; Forbes SJ
    J Hepatol; 2021 Apr; 74(4):860-872. PubMed ID: 33221352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization.
    De A; Park JI; Kawamura K; Chen R; Klein C; Rauch R; Mulders SM; Sollewijn Gelpke MD; Hsueh AJ
    Mol Endocrinol; 2006 Oct; 20(10):2528-38. PubMed ID: 16762976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation.
    Wilhelm A; Shepherd EL; Amatucci A; Munir M; Reynolds G; Humphreys E; Resheq Y; Adams DH; Hübscher S; Burkly LC; Weston CJ; Afford SC
    J Pathol; 2016 May; 239(1):109-21. PubMed ID: 26924336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.